In contrast, in chronic diseases such as IPF, pulmonary hypertension is present due to decreased pulmonary vascularity and decreased cytokines/chemokines in the lung, which may upregulate ACE2 expression. This evidence concerns the gene ACE2 and idiopathic pulmonary fibrosis.